Skip to main content

Main menu

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
  • SPECIAL ISSUES
    • Social Care Integration with Primary Care: call for articles
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
    • Top 10 Research Articles of the Year
  • BJGP CONFERENCE →
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers

User menu

  • Alerts

Search

  • Advanced search
Intended for Healthcare Professionals
BJGP Open
  • RCGP
    • British Journal of General Practice
    • BJGP for RCGP members
    • RCGP eLearning
    • InnovAIT Journal
    • Jobs and careers
  • Subscriptions
  • Alerts
  • Log in
  • Follow BJGP Open on Instagram
  • Visit bjgp open on Bluesky
  • Blog
Intended for Healthcare Professionals
BJGP Open

Advanced Search

  • HOME
  • LATEST ARTICLES
  • ALL ISSUES
  • AUTHORS & REVIEWERS
  • RESOURCES
    • About BJGP Open
    • BJGP Open Accessibility Statement
    • Editorial Board
    • Editorial Fellowships
    • Audio Abstracts
    • eLetters
    • Alerts
    • BJGP Life
    • Research into Publication Science
    • Advertising
    • Contact
  • SPECIAL ISSUES
    • Social Care Integration with Primary Care: call for articles
    • Special issue: Telehealth
    • Special issue: Race and Racism in Primary Care
    • Special issue: COVID-19 and Primary Care
    • Past research calls
    • Top 10 Research Articles of the Year
  • BJGP CONFERENCE →
Research

Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study

Hà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont and Vincent A van Vugt
BJGP Open 2025; 9 (4): BJGPO.2025.0052. DOI: https://doi.org/10.3399/BJGPO.2025.0052
Hà TN Ngo
1 Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice, Amsterdam, Netherlands
2 Amsterdam Public Health Research Institute, Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: t.n.h.ngo{at}amsterdamumc.nl
Otto R Maarsingh
1 Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice, Amsterdam, Netherlands
2 Amsterdam Public Health Research Institute, Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Otto R Maarsingh
Pauline Slottje
1 Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice, Amsterdam, Netherlands
2 Amsterdam Public Health Research Institute, Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Pauline Slottje
Marco H Blanker
3 University Medical Centre Groningen, Department of Primary and Long-term Care, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Marco H Blanker
Feikje Groenhof
3 University Medical Centre Groningen, Department of Primary and Long-term Care, Groningen, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jettie Bont
1 Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice, Amsterdam, Netherlands
2 Amsterdam Public Health Research Institute, Amsterdam, Netherlands
4 Amsterdam UMC, location AMC, Department of General Practice, Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jettie Bont
Vincent A van Vugt
1 Amsterdam UMC, location Vrije Universiteit Amsterdam, Department of General Practice, Amsterdam, Netherlands
2 Amsterdam Public Health Research Institute, Amsterdam, Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Vincent A van Vugt
  • Article
  • Figures & Data
  • Info
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1. Flowchart showing the patient selection and the number of (long-term) prescriptions. ICPC = International Classification of Primary Care
  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2. Number of patients with vestibular International Classification of Primary Care codes (N17, N17.01, N17.02, H82, H82.01, H82.02, H82.03) who received at least one anti-vertigo drug prescription.a per 1000 patients per year and the relative change in this number in 2020 versus 2018, per region in the Netherlands and for the total cohort (all practices combined). Anatomical Therapeutic Chemical codes: N07CA01, N07CA02, N07CA03, N07CA52.

    AHON = Academic General Practitioner Network Northern Netherlands. ANHA = Academic Network of General Practice Amsterdam UMC. JGPN = Julius General Practitioners’ Network. RNFM = Research Network Family Medicine

Tables

  • Figures
    • View popup
    Table 1. Characteristics of patients with vestibular symptoms and their general practices
    Patient characteristicsa (n = 73 650)
     Age (median [IQR])59 years (43–73)
     Gender (n [%])48 645 female (66)
     Diagnosed vestibular disorder (n ([%)])
      N17 (Vertigo or dizziness)31 133 (42)
      N17.01 (Rotatory vertigo)9360 (13)
      N17.02 (Lightheadedness)14 296 (19)
      H82 (Vertiginous syndrome)15 821 (21)
      H82.01 (Ménière’s disease)1650 (2)
      H82.02 (Vestibular neuritis)2503 (3)
      H82.03 (BPPV)13 651 (19)
     Comorbidity (n [%])
      Cardiovascular diseaseb 25 419 (35)
      Diabetesc 472 (1)
      Cerebrovascular diseased 5242 (7)
      Anxiety disordere 6208 (8)
      Depressive disorderf 9768 (13)
      Polypharmacyg 5011 (7)
    General practice characteristics (n = 269)
     Registered patients (n [%])
      ≤5000176 (65)
      >500093 (35)
     Employed GPs (n [%])
      193 (35)
      243 (16)
      3–465 (24)
      5–848 (18)
      >819 (7)
      Missing1 (0.4)
     Degree of urbanisation h (n [%])
      Not or hardly urbanised57 (21)
      Moderately urbanised27 (10)
      Strongly urbanised58 (22)
      Extremely urbanised124 (46)
      Missing3 (1)
    • aThis includes patients with registered vestibular International Classification of Primary Care codes (N17, N17.01, N17.02, H82, H82.01, H82.02, and/or H82.03). bInternational Classification of Primary Care codes: K86, K87, K83, K84, K75, K76. cInternational Classification of Primary Care code: T90. dInternational Classification of Primary Care codes: K89, K90. eInternational Classification of Primary Care code: P74. fInternational Classification of Primary Care code: P76.gInternational Classification of Primary Care code: A49.02. hDefinition: not or hardly urbanised =<1000 surrounding addresses. Moderately urbanised = 1000–1500 surrounding addresses. Strongly urbanised = 1500–2500 surrounding addresses. Extremely urbanised =>2500 surrounding addresses.

    • BPPV = benign paroxysmal positional vertigo.

    • View popup
    Table 2. Characteristics associated with long-term anti-vertigo drug prescriptions (that is, prescriptions for a total duration of 90 days or more in 12 months’ time)
    Characteristic Long-term prescription
    (≥90 days within 12 months)
    (n = 3382)
    No long-term prescription (<90 days within 12 months)
    (n = 6079)
    Univariable analysis (OR [95% CI]) Multivariable analysis (OR [95%CI])
    Age (median [IQR])73 (62–82)62 (49–75)1.04 (1.04 to 1.04)a 1.04 (1.03 to 1.04)a
    Sex, female (%)71720.99 (0.91 to 1.09)1.03 (0.93 to 1.14)
    Vestibular symptom or disorder (%)
     N17 (Vertigo or dizziness)15131.16 (1.02 to 1.31)a 1.06 (0.93 to 1.21)
     N17.01 (Rotatory vertigo)450.86 (0.70 to 1.05)0.87 (0.70 to 1.08)
     N17.02 (Lightheadedness)230.62 (0.46 to 0.83)a 0.54 (0.39 to 0.74)a
     H82 (Vertiginous syndrome)991.05 (0.91 to 1.22)0.97 (0.83 to 1.14)
     H82.01 (Ménière’s disease)1134.44 (3.68 to 5.34)a 4.15 (3.42 to 5.05)a
     H82.02 (Vestibular neuritis)120.73 (0.50 to 1.05)0.82 (0.56 to 1.21)
     H82.03 (BPPV)580.62 (0.52 to 0.75)a 0.68 (0.57 to 0.83)a
    Comorbidity (%)
     K86 (Hypertension, uncomplicated)36261.56 (1.43 to 1.71)a 1.07 (0.96 to 1.18)
     K87 (Hypertension, complicated)751.56 (1.29 to 1.87)a 1.02 (0.84 to 1.25)
     K83 (Heart valve disease)211.54 (1.09 to 2.16)a 0.96 (0.67 to 1.38)
     K84 (Heart disease, other)212.11 (1.50 to 2.96)a 1.35 (0.94 to 1.95)
     K75 (Acute myocardial infarction)641.70 (1.39 to 2.08)a 1.12 (0.90 to 1.39)
     K76 (Ischaemic heart disease without angina)211.76 (1.26 to 2.46)a 1.16 (0.82 to 1.65)
     K89 (Transient cerebral ischaemia)641.57 (1.29 to 1.91)a 0.97 (0.79 to 1.19)
     K90 (Stroke or cerebrovascular accident)421.55 (1.22 to 1.97)a 1.00 (0.77 to 1.29)
     T90 (Diabetes)111.35 (0.79 to 2.30)1.22 (0.70 to 2.13)
     P74 (Anxiety disorder or anxiety state)560.86 (0.71 to 1.03)1.05 (0.86 to 1.29)
     P76 (Depressive disorder)10110.91 (0.79 to 1.04)1.03 (0.89 to 1.20)
     A49.2 (Polypharmacy)741.79 (1.49 to 2.14)a 1.06 (0.87 to 1.29)
    Registered patients (%)
     >5000 (in comparison with≤5000)55%53%1.11 (1.02 to 1.21)a 1.12 (0.99 to 1.26)
    Employed GPs (%)
     1b 25271.01.0
     212111.14 (0.98 to 1.32)1.15 (0.98 to 1.35)
     3–428271.11 (0.99 to 1.24)1.06 (0.93 to 1.20)
     5–823231.06 (0.94 to 1.19)1.11 (0.95 to 1.30)
     >812121.10 (0.95 to 1.27)1.04 (0.86 to 1.26)
    Degree of urbanisation (%)c
      Not or hardly urbanisedb 23211.01.0
     Moderately urbanised17131.14 (0.99 to 1.32)1.10 (0.94 to 1.28)
     Strongly urbanised29290.90 (0.80 to 1.01)0.95 (0.83 to 1.08)
     Extremely urbanised30360.75 (0.66 to 0.84)a 0.82 (0.72 to 0.93)a
    • aSignificant association, P<0.05. bReference category. cDefinition: not/hardly urbanised = <1000 surrounding addresses. Moderately urbanised =1000–1500 surrounding addresses. Strongly urbanised = 1500–2500 surrounding addresses. Extremely urbanised = >2500 surrounding addresses. BPPV = benign paroxysmal positional vertigo. CI = confidence interval. OR = odds ratio

Supplementary Data

  • HTTN_10.3399BJGPO.2025.0052_supp_v1.pdf -

    Supplementary material is not copyedited or typeset, and is published as supplied by the author(s). The author(s) retain(s) responsibility for its accuracy.

Back to top
Previous ArticleNext Article

In this issue

BJGP Open
Vol. 9, Issue 4
December 2025
  • Table of Contents
  • Index by author
Download PDF
Download PowerPoint
Email Article

Thank you for recommending BJGP Open.

NOTE: We only request your email address so that the person to whom you are recommending the page knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study
(Your Name) has forwarded a page to you from BJGP Open
(Your Name) thought you would like to see this page from BJGP Open.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study
Hà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont, Vincent A van Vugt
BJGP Open 2025; 9 (4): BJGPO.2025.0052. DOI: 10.3399/BJGPO.2025.0052

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study
Hà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont, Vincent A van Vugt
BJGP Open 2025; 9 (4): BJGPO.2025.0052. DOI: 10.3399/BJGPO.2025.0052
del.icio.us logo Facebook logo Mendeley logo Bluesky logo
  • Tweet Widget
  • LinkedIn logo LinkedIn
  • Mendeley logo Mendeley
  • Bluesky logo Bluesky

Jump to section

  • Top
  • Article
    • Abstract
    • How this fits in
    • Introduction
    • Method
    • Results
    • Discussion
    • Notes
    • References
  • Figures & Data
  • Info
  • eLetters
  • PDF

Keywords

  • vestibular symptoms
  • dizziness
  • vertigo
  • anti-vertigo drugs
  • inappropriate drug prescribing
  • General Practice

More in this TOC Section

  • Slow walking speed and risk of cardiovascular events in type 2 diabetes: a systematic review
  • Experiences of dyslexia in GP training in the UK: a qualitative study
  • Acceptability and utility of parental guidance on weight talk with children for GPs: a qualitative study
Show more Research

Related Articles

Cited By...

Intended for Healthcare Professionals

 
 

British Journal of General Practice

NAVIGATE

  • Home
  • Latest articles
  • Authors & reviewers
  • Accessibility statement

RCGP

  • British Journal of General Practice
  • BJGP for RCGP members
  • RCGP eLearning
  • InnovAiT Journal
  • Jobs and careers

MY ACCOUNT

  • RCGP members' login
  • Terms and conditions

NEWS AND UPDATES

  • About BJGP Open
  • Alerts
  • RSS feeds
  • Facebook
  • Twitter

AUTHORS & REVIEWERS

  • Submit an article
  • Writing for BJGP Open: research
  • Writing for BJGP Open: practice & policy
  • BJGP Open editorial process & policies
  • BJGP Open ethical guidelines
  • Peer review for BJGP Open

CUSTOMER SERVICES

  • Advertising
  • Open access licence

CONTRIBUTE

  • BJGP Life
  • eLetters
  • Feedback

CONTACT US

BJGP Open Journal Office
RCGP
30 Euston Square
London NW1 2FB
Tel: +44 (0)20 3188 7400
Email: bjgpopen@rcgp.org.uk

BJGP Open is an editorially-independent publication of the Royal College of General Practitioners

© 2026 BJGP Open

Online ISSN: 2398-3795